Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Annals of the New York Academy of Sciences|May 3, 2003
CD137-mediated T cell co-stimulation terminates existing autoimmune disease in SLE-prone NZB/NZW F1 miceJuergen Foell, Megan McCausland, Jennifer Burch, et al.Infection and Immunity|December 24, 2002
4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniaeZheng-Qi Wu, Abdul Q Khan, Yi Shen, et al.Nature Medicine|May 9, 2006
Eradication of established tumors in mice by a combination antibody-based therapyTomoyasu Uno, Kazuyoshi Takeda, Yuko Kojima, et al.Infection and Immunity|February 7, 2007
Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccineElsa M Laughlin, Joseph D Miller, Eddie James, et al.Journal of Autoimmunity|October 23, 2013
Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic miceKritika Kachapati, Kyle J Bednar, David E Adams, et al.Immunology|August 18, 2004
Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistanceJuergen L Foell, Belkis I Diez-Mendiondo, Oliver H Diez, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated miceLiguo Niu, Simona Strahotin, Becker Hewes, et al.The Journal of Clinical Investigation|September 15, 2007
Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependentBenyue Zhang, Charles H Maris, Juergen Foell, et al.Frontiers in Immunology|December 3, 2019
Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell AnergyArata Itoh, Lorenzo Ortiz, Kritika Kachapati, et al.Vaccine|October 20, 2009
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicityRich-Henry Schabowsky, Kutlu G Elpek, Shravan Madireddi, et al.Pageof 6